Prescribing information

 

Useful tools and resources for HCPs to support the use of Beovu in day-to-day practice.

We have developed a number of resources for you to share with your patients who have been prescribed Beovu.

These are designed to help Beovu patients better understand their condition and treatment, monitor and manage their symptoms, and know where to look for further support.

Video preview 'Beovu is indicated in adults for the treatment of neovascular (wet) age-related macular degeneration (AMD) – Pre-filled syringe preparation video

Pre-filled syringe preparation video

A short video explaining how to prepare the Beovu pre-filled syringe for wet AMD.

Watch here

 

Document preview 'Monitoring card': An informative card that outlines some of the possible side effects and changes in vision to monitor post Beovu treatment.

Monitoring card 

An informative card that outlines some of the possible side effects and changes in vision to monitor post Beovu treatment

A printed version is available from the prescribing HCP.

Document preview 'Patient booklet': Information for patients about wet age-related macular degeneration (AMD), what Beovu is, and contact details for further support from patient organisations.

Patient booklet

Information for patients about wet age-related macular degeneration (AMD), what Beovu is, and contact details for further support from patient organisations.

View

Document preview 'Post-treatment care guide': Information for patients to help them understand what to expect after treatment and how to spot any changes in sight early.

Post-treatment care guide

Information for patients to help them understand what to expect after treatment and how to spot any changes in sight early. This resource includes a vision journal in the second half of the booklet, which allows patients to keep a record of any changes they might encounter following their Beovu treatment.

View

 

AMD, age-related macular degeneration; HCP, healthcare professional.

Rate this content: 
Average: 5 (1 vote)
UK | August 2021 | 149275
×

Ask Speakers

×

Medical Information Request

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]